Agreed... I am not personally aware of personalized vaccines that are significantly beyond pre-clinical development. My point was that we should be grateful that ADXS management has been keeping their eye on the ball, recognizing the future direction of the dynamic space of personalized vaccines and developing new product candidates that represent state of the art.
As for those companies I mentioned in particular.. I wasn't at all pumping them and do not have detailed DD into their science (but I think AGEN is the farthest along of the three I mentioned). Welcome knowledgeable comments from those more scientifically oriented than I to elaborate :)
News 
Market Data 
Discover 
